MoneyWorks4Me

The revenue for the March 2023 quarter is pegged at Rs. 6964.10 millions, about 8.56% up against Rs. 6414.80 millions recorded during the year-ago period.A meek growth of 0.32% was reported for the quarter ended March 2023 to Rs. 531.70  millions from Rs. 530.00 millions.The company reported a good operating profit of 894.50 millions compared to 847.20 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 6964.10 6414.80 8.56 24979.70 22511.70 10.96 24979.70 22511.70 10.96
Other Income 9.30 6.20 50.00 22.30 47.80 -53.35 22.30 47.80 -53.35
PBIDT 894.50 847.20 5.58 2846.30 3229.50 -11.87 2846.30 3229.50 -11.87
Interest 83.50 58.40 42.98 325.30 200.60 62.16 325.30 200.60 62.16
PBDT 811.00 788.80 2.81 2521.00 3028.90 -16.77 2521.00 3028.90 -16.77
Depreciation 116.80 118.80 -1.68 472.90 473.90 -0.21 472.90 473.90 -0.21
PBT 694.20 670.00 3.61 2048.10 2555.00 -19.84 2048.10 2555.00 -19.84
TAX 162.50 140.00 16.07 520.00 605.00 -14.05 520.00 605.00 -14.05
Deferred Tax -15.00 -35.00 -57.14 -12.50 -50.00 -75.00 -12.50 -50.00 -75.00
PAT 531.70 530.00 0.32 1528.10 1950.00 -21.64 1528.10 1950.00 -21.64
Equity 926.00 926.00 0.00 926.00 926.00 0.00 926.00 926.00 0.00
PBIDTM(%) 12.84 13.21 -2.74 11.39 14.35 -20.57 11.39 14.35 -20.57
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..